Role of Copper in the Onset of Alzheimer's Disease Compared to Other Metals

被引:165
作者
Bagheri, Soghra [1 ]
Squitti, Rosanna [2 ]
Haertle, Thomas [3 ,4 ,5 ]
Siotto, Mariacristina [6 ]
Saboury, Ali A. [3 ]
机构
[1] Kermanshah Univ Med Sci, Med Biol Res Ctr, Kermanshah, Iran
[2] IRCCS Ist Ctr San Giovanni Dio Fatebenefratelli, Mol Markers Lab, Brescia, Italy
[3] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran
[4] INRA, UR Biopolymeres Interact Assemblages 1268, Equipe Fonct & Interact Prot, Nantes, France
[5] Poznan Univ Life Sci, Dept Anim Nutr & Feed Management, Poznan, Poland
[6] Fdn Don Carlo Gnocchi Onlus, Milan, Italy
来源
FRONTIERS IN AGING NEUROSCIENCE | 2018年 / 9卷
关键词
Alzheimer's disease; copper; zinc; neurodegenerative disorder; amyloid plaques; cholesterol; calcium; AMYLOID-PRECURSOR-PROTEIN; LONG-TERM POTENTIATION; ABANDONING THERAPEUTIC CHELATION; ADENOSINE-DEAMINASE INHIBITORS; DITYROSINE CROSS-LINKING; NON-CERULOPLASMIN COPPER; TRANSGENIC MOUSE MODEL; SENILE PLAQUE CORES; A-BETA; OXIDATIVE STRESS;
D O I
10.3389/fnagi.2017.00446
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Alzheimer's disease (AD) is a neurodegenerative disorder that is characterized by amyloid plaques in patients' brain tissue. The plaques are mainly made of beta-amyloid peptides and trace elements including Zn2+, Cu2+, and Fe2+. Some studies have shown that AD can be considered a type of metal dyshomeostasis. Among metal ions involved in plaques, numerous studies have focused on copper ions, which seem to be one of the main cationic elements in plaque formation. The involvement of copper in AD is controversial, as some studies show a copper deficiency in AD, and consequently a need to enhance copper levels, while other data point to copper overload and therefore a need to reduce copper levels. In this paper, the role of copper ions in AD and some contradictory reports are reviewed and discussed.
引用
收藏
页数:15
相关论文
共 253 条
[1]   Copper Promotes the Trafficking of the Amyloid Precursor Protein [J].
Acevedo, Karla M. ;
Hung, Ya Hui ;
Dalziel, Andrew H. ;
Li, Qiao-Xin ;
Laughton, Katrina ;
Wikhe, Krutika ;
Rembach, Alan ;
Roberts, Blaine ;
Masters, Colin L. ;
Bush, Ashley I. ;
Camakaris, James .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (10) :8252-8262
[2]   Kinetic, thermodynamic and statistical studies on the inhibition of adenosine deaminase by aspirin and diclofenac [J].
Ajloo, Davood ;
Saboury, Ali A. ;
Haghi-Asli, Niloofar ;
Ataei-Jafarai, Ghasem ;
Moosavi-Movahedi, Ali A. ;
Ahmadi, Mosayeb ;
Mahnam, Karim ;
Namaki, Saeed .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2007, 22 (04) :395-406
[3]   A central role for dityrosine crosslinking of Amyloid-β in Alzheimer's disease [J].
Al-Hilaly, Youssra K. ;
Williams, Thomas L. ;
Stewart-Parker, Maris ;
Ford, Lenzie ;
Skaria, Eldhose ;
Cole, Michael ;
Bucher, William Grant ;
Morris, Kyle L. ;
Sada, Alaa Abdul ;
Thorpe, Julian R. ;
Serpell, Louise C. .
ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2013, 1
[4]  
Angulo E, 2003, BRAIN PATHOL, V13, P440
[5]  
Arbor Sage C., 2016, Yale Journal of Biology and Medicine, V89, P5
[6]   What causes Alzheimer's disease? [J].
Armstrong, Richard A. .
FOLIA NEUROPATHOLOGICA, 2013, 51 (03) :169-188
[7]  
Arnal N., 2013, INT J ALZHEIMERS DIS, V2013, P645379, DOI [10.1155/2013/645379, DOI 10.1155/2013/645379]
[8]  
Arnal Nathalie, 2013, Int J Alzheimers Dis, V2013, P414817, DOI 10.1155/2013/414817
[9]   Kinetic and structural analysis of the inhibition of adenosine deaminase by acetaminophen [J].
Ataie, G ;
Safarian, S ;
Divsalar, A ;
Saboury, AA ;
Moosavi-Movahedi, AA ;
Ranjbar, B ;
Cristalli, G ;
Mardanian, S .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2004, 19 (01) :71-78
[10]  
Ataie G, 2007, IRAN J PHARM RES, V6, P43